Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Connie W Batlevi"'
Autor:
Harper Hubbeling, Emily Silverman, Neil Ari Wijetunga, M. Lia Palomba, Ana Alarcon Tomas, Roni Shouval, Connie W Batlevi, Parastoo B. Dahi, Sergio A Giralt, Richard J. Lin, Jae H Park, Michael Scordo, Craig S. Sauter, Gunjan Shah, Miguel-Angel Perales, Carla Hajj, Joachim Yahalom, Brandon S. Imber
Publikováno v:
Transplantation and Cellular Therapy. 28:S423-S424
Autor:
Brandon S. Imber, Harper Hubbeling, Emily Silverman, Neil Ari Wijetunga, M. Lia Palomba, Ana Alarcon Tomas, Roni Shouval, Connie W Batlevi, Parastoo B. Dahi, Sergio A Giralt, Richard J. Lin, Jae H Park, Michael Scordo, Craig S. Sauter, Gunjan Shah, Miguel-Angel Perales, Carla Hajj, Joachim Yahalom
Publikováno v:
Transplantation and Cellular Therapy. 28:S211-S212
Autor:
Pamela Drullinsky, Anita Kumar, Neena Mahajan, Connie W. Batlevi, Andrew D. Zelenetz, A. Joseph, Paul A. Hamlin, Clare Grieve, Leana Laraque, David J. Straus, M. Matasar
Publikováno v:
Hematological Oncology. 39
Introduction: Bendamustine (B) and rituximab (R) with ibrutinib (IBR) was well-tolerated and efficacious (Maddocks Blood 2015). Ibrutinib and venetoclax (VEN) were synergistic and active in relapsed, refractory (R/R) MCL (Tam NEJM 2018). VEN increase
Autor:
Karthik Nath, Ana Alarcon Tomas, Jessica Flynn, Joshua A Fein, Anna Alperovich, Theodora Anagnostou, Connie W Batlevi, Parastoo B. Dahi, Warren Fingrut, Sergio A Giralt, Richard J. Lin, M. Lia Palomba, Jonathan U. Peled, Gilles Salles, Craig S. Sauter, Michael Scordo, Nishi Shah, John Slingerland, Sean M. Devlin, Gunjan Shah, Miguel-Angel Perales, Roni Shouval
Publikováno v:
Transplantation and Cellular Therapy. 28:S175
Autor:
Yunxin Chen, Molly Maloy, Jae H. Park, Elizabeth Halton, Sham Mailankody, Gunjan L. Shah, Terence J. Purdon, Connie W. Batlevi, Elena Mead, Melody Smith, Tania Jain, Craig S. Sauter, Josel D. Ruiz, Sergio Giralt, Andrea Knezevic, Michael Scordo, Eric Alden Smith, Claudia Diamonte, Renier J. Brentjens, Miguel-Angel Perales, M. Lia Palomba, Martina Pennisi, Bianca Santomasso, Sean M. Devlin
Publikováno v:
Blood Adv
Factors contributing to hematopoietic recovery following chimeric antigen receptor (CAR) T-cell therapy have not been well studied. In an analysis of 83 patients with hematologic malignancies treated with CAR T-cell therapy, we describe patterns of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfc2f68eaab955782d25df157d397a6
https://europepmc.org/articles/PMC7422135/
https://europepmc.org/articles/PMC7422135/
Autor:
Elizabeth Halton, Michael Scordo, Aishat Afuye, M. Lia Palomba, Craig S. Sauter, Gunjan L. Shah, Sergio Giralt, Jessica Flynn, Parastoo B. Dahi, Martina Pennisi, Sean M. Devlin, Mari Lynne Silverberg, Bianca Santomasso, Kitsada Wudhikarn, Rosalia Alonso-Trillo, Miguel-Angel Perales, Elena Mead, Connie W. Batlevi, Molly Maloy, Josel D. Ruiz, Marta Garcia-Recio, Roni Shouval
Publikováno v:
Transplant Cell Ther
CD19-targeted chimeric antigen receptor (CAR) T cells have shown excellent activity against relapsed and refractory (R/R) diffuse large B cell lymphoma (DLBCL). CAR T cell therapy is associated with early toxicities, including cytokine release syndro
Autor:
David J. Straus, Anita Kumar, Michael Scordo, Alayna Santarosa, Oscar B Lahoud, Jennifer Lyons, Gottfried von Keudell, Connie W. Batlevi, Gunjan L. Shah, Helen Hancock, Theresa Davey, Craig H. Moskowitz, Craig S. Sauter, Samia Sohail, Joachim Yahalom, Matthew J. Matasar, Josel D. Ruiz, Alison J. Moskowitz, Miguel-Angel Perales, Ildefonso Rodriguez-Rivera, Nivetha Ganesan, Parastoo B. Dahi, Philip Caron, Paul A. Hamlin
Publikováno v:
Transplantation and Cellular Therapy. 27:S68-S69
Autor:
Kitsada Wudhikarn, Michael Scordo, Miguel Perales, Gunjan L. Shah, Martha Garcia Recio, Parastoo B. Dahi, Sean M. Devlin, Jessica Flynn, Molly Maloy, Craig S. Sauter, M. Lia Palomba, Martina Pennisi, Connie W. Batlevi
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S263-S264
Introduction Despite the remarkable activity of chimeric antigen receptor T (CAR T) cells in relapsed/refractory aggressive B cell non-Hodgkin Lymphoma (B-NHL), they possess unique and significant adverse effect profiles, notably cytokine release syn
Autor:
Yakup Batlevi, Gunjan L. Shah, Roni Shouval, Craig S. Sauter, Miguel Perales, Jae H. Park, Miriam Sanchez-Escamilla, Elena Mead, Sean M. Devlin, Parastoo B. Dahi, Bianca Santomasso, Michael Scordo, Molly Maloy, Connie W. Batlevi, Martina Pennisi, Mari Lynne Silverberg, M. Lia Palomba, Tania Jain, Sergio Giralt, Claudia Diamonte, Renier J. Brentjens, Elizabeth Halton
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S40-S41
Introduction Cytokine release syndrome (CRS) and immune effector cells associated neurotoxicity syndrome (ICANS) are common CAR T cells toxicities. Various grading systems that attribute different grades of severity to symptoms are currently used, pr
Autor:
Michael Scordo, Sham Mailankody, Bianca Santomasso, Eric Alden Smith, Gunjan L. Shah, Jae H. Park, Molly Maloy, Elena Mead, Andrea Knezevic, Craig S. Sauter, Elizabeth Halton, Miguel Perales, Tania Jain, Connie W. Batlevi, Claudia Diamonte, Renier J. Brentjens, Sean M. Devlin, Martina Pennisi, M. Lia Palomba, Josel D. Ruiz
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S63-S64
Background Cytopenias are observed post-CAR T, yet there is minimal data delineating the pathobiology and trends thereof. We report the largest series to our knowledge thus far, of hematopoietic recovery post-CAR T and factors affecting this recovery